Business Wire3m
Italfarmaco Provides Overview on Givinostat as Treatment for Duchenne Muscular Dystrophy: Progress in Global Access, Regulatory Milestones and Clinical Trials
Italfarmaco S.p.A. today announced a comprehensive update on the regulatory and clinical advancements for givinostat, the ...
Ocugen, Inc. (NASDAQ:OCGN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 5, 2025 Ocugen, Inc. reports earnings inline with expectations. Reported EPS is $-0.05 EPS, expectations were $-0.05. Operator: Good morning, and welcome to ...
Trump latest news: Top adviser says Canada ‘taken over by Mexican cartels’ amid brewing trade war
Top adviser says Canada ‘taken over by Mexican cartels’ amid brewing trade war - Peter Navarro rages at northern neighbor after administration grants 30-day tariff relief to U.S. auto sector ...
TMCnet52m
New Data Presented at CORA 2025 Conference Highlights Clinical Potential of Chemomab's Nebokitug in Systemic Sclerosis
Adds to Extensive Preclinical and Early Clinical Evidence that Nebokitug Interferes with Key Features of Systemic Sclerosis. TEL AVIV, Israel, (GLOBE NEWSWIRE) -- C ...